Kura Oncology KURA
NASDAQ KURA
$10.65 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kura Oncology (KURA) Depreciation & Amortization (CF) (2014 - 2026)

Updated

Kura Oncology (KURA) recorded Depreciation & Amortization (CF) of $369,000 in Q2 2026, up 64.7% from $224,000 a year earlier and up 3.9% from the prior quarter.

Analysis

Kura Oncology (KURA) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends

On a TTM basis, Kura Oncology's Depreciation & Amortization (CF) came in at $1.29 million as of Jun 30, 2026, up 47.2% year-over-year; for FY2025, it came in at $1.03 million, up 21.7% from FY2024.

  • Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of 38.8% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $848,000 in FY2024 (-0.1%), $849,000 in FY2023 (+6.1%), $800,000 in FY2022 (+33.3%) and $600,000 in FY2021 (+200.0%).
  • Quarterly Depreciation & Amortization (CF) has ranged from $160,000 in Q3 2021 to $403,000 in Q4 2025 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased for three consecutive quarters, with growth averaging 24.2% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 116.2% in Q3 2021, against a decline of 21.2% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $355,000 (Q1 2026), $403,000 (Q4 2025) and $164,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.93 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.62 Bn
10 Kura Oncology 947.36 Mn 947.36 Mn 20.63 Mn 369,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 369,000.00
Mar 31, 2026 355,000.00
Dec 31, 2025 403,000.00
Sep 30, 2025 164,000.00
Jun 30, 2025 224,000.00
Mar 31, 2025 241,000.00
Dec 31, 2024 204,000.00
Sep 30, 2024 208,000.00
Jun 30, 2024 202,000.00
Mar 31, 2024 234,000.00
Dec 31, 2023 214,000.00
Sep 30, 2023 216,000.00
Jun 30, 2023 213,000.00
Mar 31, 2023 206,000.00
Dec 31, 2022 247,000.00
Sep 30, 2022 193,000.00
Jun 30, 2022 183,000.00
Mar 31, 2022 177,000.00
Dec 31, 2021 208,000.00
Sep 30, 2021 160,000.00
API Access

Kura Oncology Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=KURA&period=max&api_key=YOUR_API_KEY